Ozempic And Other Weight Loss Drugs Will Only Work With Digital Health

Weight loss injections are now widely used as miracle drugs for effortless skinniness. But without digital health, they just won’t work in the long run. The U.S. Food and Drug Administration, the FDA, approved Wegovy, a semaglutide injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition for use in addition to a reduced calorie diet and increased physical activity in 2021.  Semaglutide was originally used for the treatment of type 2 diabetes, and was found to have a major lucky side effect: being very effective in assisting weight loss. Semaglutide injections are sold under different brand names: Ozempic and Rybelsus are supposed to be prescribed to diabetes patients, while Wegovy was specifically developed for treating obesity.  These drugs belong to the group of GLP-1 receptor agonists, a category everybody just calls weight loss injections. The miracle-drug epidemic In the past few years, Ozempic (and the rest) has become a household name for the wealthy families of the most developed countries. It is best known as the miracle drug that makes you skinny without any effort, something that you can easily lay your hands on if you are ok with paying the $1000+ monthly price of moderate appetite. Regardless of whether you are supposed to get the injections from the medical point of view. How come these drugs became a magic injection epidemic marketed by 19-year-old influencers on TikTok and A-...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Digital Health Research weight management weight loss Ozempic Wagevy Source Type: blogs